Breakwater Investment Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.79K Sell
27
-52
-66% -$11.2K ﹤0.01% 252
2026
Q1
$17.2K Sell
79
-15
-16% -$3.33K 0.01% 203
2025
Q4
$21.5K Hold
94
– – 0.01% 189
2025
Q3
$21.8K Buy
94
+29
+45% +$5.91K 0.01% 192
2025
Q2
$12.1K Hold
65
– – ﹤0.01% 216
2025
Q1
$13.6K Hold
65
– – 0.01% 209
2024
Q4
$11.6K Hold
65
– – ﹤0.01% 212
2024
Q3
$12.8K Sell
65
-66
-50% -$12.3K 0.01% 212
2024
Q2
$22.5K Buy
131
+66
+102% +$10.9K 0.01% 182
2024
Q1
$11.8K Buy
+65
New +$11.2K 0.01% 207

Other funds holding ABBV

Breakwater Investment Management's ABBV Position: Q2 2026 in Review

Breakwater Investment Management reduced its AbbVie (ABBV) stake by 66% in Q2 2026, selling an estimated $11.2K and leaving 27 shares worth $6.79K. The position accounts for ﹤0.01% of the portfolio, ranked #252.

Breakwater Investment Management first reported a position in ABBV in Q1 2024 and has held it in 10 quarters since. The position peaked at $22.5K in Q2 2024. 4,234 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Breakwater Investment Management held 27 shares of AbbVie worth $6.79K as of Q2 2026.
  • Breakwater Investment Management sold 52 AbbVie shares in Q2 2026, an estimated $11.2K.
  • AbbVie made up ﹤0.01% of Breakwater Investment Management's portfolio in Q2 2026, its #252 holding.
  • Breakwater Investment Management first reported a position in AbbVie in Q1 2024 and has held it in 10 quarters since.
  • Breakwater Investment Management's AbbVie position peaked at $22.5K in Q2 2024.
  • 4,234 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Breakwater Investment Management's 13F filing for Q2 2026, filed 6 Aug 2026.